Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Immunohistochemistry × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 3 Colorectal Neoplasms 3 Rectal Neoplasms 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Colonic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Teratoma, Testicular 1 Teratoma 1 Solid Tumors With High Expression of Nectin4 1 Recurrence 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Glioma 1 Endodermal Sinus Tumor 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡